The Issuer shall in connection with the issue of its Financial Statements under Clause 13.2.1. (b), confirm to the Bond Trustee in writing the Issuer's compliance with the covenants in Clause 13. Such confirmation shall be undertaken in a compliance certificate, substantially in the format set out in Attachment 1 hereto, signed by the Chief Executive Officer or Chief Financial Officer of the Issuer. In the event of noncompliance, the compliance certificate shall describe the non-compliance, the reasons therefore as well as the steps which the Issuer has taken and will take in order to rectify the non-compliance.
(a) Pari passu ranking The Issuer's obligations under this Agreement and any other Finance Document shall at all times rank at least pari passu with the claims o f all its other unsubordinated creditors save for those whose claims are preferred solely by any bankruptcy, insolvency, liquidation or other similar laws o f general application.
(b) Mergers The Issuer shall not carry out any merger or other business combination or corporate reorganization involving consolidating the assets and obligations of the Issuer with any other companies or entities if such transaction would have a Material Adverse Effect.
(c) De-mergers The Issuer shall not carry out any de-merger or other corporate reorganization involving splitting the Issuer into two or more separate companies or entities, if such transaction would have a Material Adverse Effect.
(d) Continuation o f business The Issuer shall not cease to carry out its business. The Issuer shall procure that no material change is made to the general nature or scope of the business o f the Issuer from that carried on at the date o f this Bond Agreement or as contemplated by this Bond Agreement.
17
Norsk Tillitsmann ASA
(e) Disposal o f business The Issuer shall not be entitled to sell or otherwise dispose o f all or a substantial part o f its assets or operations, unless such transaction is carried out at a fair market value on terms and conditions customary for such transactions and would not have a Material Adverse Effect.
13.4 Corporate and operational matters
